Announcements Trials

Browse Landscape

Status

Completed 3 Unknown 2 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 8 Colorectal Neoplasms 7 Prostatic Neoplasms 6 Stomach Neoplasms 5 Lung Neoplasms 5 Breast Neoplasms 5 Endometrial Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma 3 Pancreatic Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Oropharyngeal Neoplasms 2 Obesity 2 Meningioma 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Esophageal Neoplasms 2 Disease 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma, Basal Cell 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Surgical Wound Dehiscence 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Small Cell Lung Carcinoma 1 Skull Base Neoplasms 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1

Interventions

Dexamethasone 87 daratumumab 49 Lenalidomide 49 pomalidomide 33 Bortezomib 32 Cyclophosphamide 31 carfilzomib 25 Calcium Dobesilate 21 talquetamab 19 fludarabine 18 isatuximab 16 iberdomide 16 Magnetic Resonance Spectroscopy 16 Specimen Handling 15 Biopsy 14 selinexor 12 Melphalan 11 belantamab mafodotin 10 dexamethasone acetate 9 dexamethasone 21-phosphate 8 elotuzumab 7 auricularum 7 venetoclax 6 tocilizumab 5 fludarabine phosphate 5 X-Rays 5 Blood Specimen Collection 5 ruxolitinib 4 Methylprednisolone 4 Injections 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Multiple Myeloma × Observation × Clear all

NCT05001087 2025-02-27

MY MYELOMA

Fondazione EMN Italy Onlus

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡